the aid library

LIST OPTIONS

Filter

6574

Sort by:

Direction:

Download (45)

View PDF (664)

Partnership to Accelerate COVID-19 Testing (PACT) in Africa – Social media materials

Africa CDC Centers for Disease Control and Prevention (2020) CC

To help increase continental testing efforts and reduce COVID-19 transmission in Africa, Africa CDC has launched the Partnership to Accelerate COVID-19 Testing (PACT): Test, Trace, Treat. PACT will mobilize experts, community workers, supplies and other resources to TEST, TRACE and TREAT COVID-19 c... more

Download (116)

View PDF (155)

Monkeypox multi-country outbreak. Rapid Risk Assessment

European Centre for Disease Prevention and Control (ECDC) (2022) C2

Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands). Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact ... more

Download (124)

View PDF (142)

Considerations relating to social distancing measures in response to the COVID-19 epidemic- second update

European Centre for Disease Prevention and Control ECDC (2020) C1

Social distancing is an action taken to minimise contact with other individuals; social distancing measures comprise one category of non-pharmaceutical countermeasures (NPCs)1 aimed at reducing disease transmission and thereby also reducing pressure on health services. This document builds upon exi... more

Download (54)

View PDF (45)

Implications of the Marburg virus disease outbreak in Rwanda for the EU/EEA, 2024

European Centre for Disease Prevention and Control (ecdc) (2024) C_CDC

This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and, although uncommon, it has the potential to cause epidemics with significant case fatality. ... more

Download (500)

View PDF (998)

Safe use of personal protective equipment in the treatment of infectious diseases of high consequence

European Centre for Disease Prevention and Control (2014) C1

A tutorial for trainers in healthcare settings Version 2: 2 Dec 2014 "The document focuses on an extended set of PPE components, which includes goggles, respirators, gloves, coveralls and footwear. Used properly, these PPE components can provide effective protection even from airborne transmissi... more

Download (104)

View PDF (107)

Guidance on easing lockdown

Africa CDC Centers for Disease Control and Prevention (2020) CC

In response to the first cases of coronavirus disease 2019 (COVID-19) reported on the continent, many African Union Member States implemented large-scale public health and social measures (PHSM) rapidly. These measures were aimed at reducing transmission and the number of new cases being reported, p... more

Download (151)

View PDF (189)

Community use of face masks
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2020) C1

Update 1 October 2020. This document provides guidance to Member States on the effective use of face masks/coverings in the community by individuals without COVID-19 symptoms in order to reduce potential transmission of SARS-CoV-2.a It also provides advice on the use of masks during home care for ... more

Download (80)

View PDF (1014)

Interim Guidance for a Public Health Response to Contain Novel or Targeted Multidrug-resistant Organisms (MDROs)

Center for Disease Control and Prevention CDC (2019) C_CDC

This document is intended for use by state and local health departments and healthcare facilities and serves as general guidance for the initial response for the containment of novel or targeted multidrug-resistant organisms (MDROs) or resistance mechanisms. It is not intended to describe all the ac... more

Download (289)

View PDF (2286)

SURVEILLANCE ATLAS: EBOLA OUTBREAK, WEST AFRICA

ECDC (European Centre for Disease Prevention and Control) (2015) CC2

A tool for easy access to infectious disease surveillance data related to the Ebola Virus Disease (EVD) outbreak currently evolving in West Africa. The atlas is based on the best available data on EVD cases in the countries with community transmission and on medical evacuations of patients and peop... more

Download (140)

View PDF (870)

Best Practices for Environmental Cleaning in Healthcare Facilities: in Resource-Limited Settings

Centers for Disease Control and Prevention CDC (2019) C_CDC

Healthcare-associated infections (HAI) are a significant burden globally, with millions of patients affected each year. These infections affect both high- and limited-resource healthcare settings, but in limited-resource settings, rates are approximately twice as high as high-resource settings (15 o... more

Download (58)

View PDF (538)

Framework for Implementation of COVID-19 Community Mitigation Measures for Lower-Resource Countries

Centers for Disease Control and Prevention CDC (2020) C_CDC

The purpose of this document is to provide ministries (e.g. Ministry of Health (MOH), Ministry of Water (MOW)), sub-national public health authorities, and implementing partners with a practical framework of action to both prepare for and mitigate community transmission of COVID-19. The document doe... more

Download (97)

View PDF (138)

Décontamination de l’environnement dans le cadre de la COVID-19

African Union; Africa CDC Centres for Disease Control and Prevention (2020) C1

Ces orientations vous proposent les principes et procédures de base en matière de décontamination de l'environnement physique dans le contexte de la pandémie du coronavirus 2019 (COVID-19). La contamination des surfaces et les risques de transmission des maladies diffèrent ... more

Download (96)

View PDF (143)

Africa CDC Consortium for COVID-19 Vaccine Clinical Trials (CONCVACT)

African Union; Africa CDC Centres for Disease Control and Prevention (2020) C1

August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associated harms. Participation by African nations in clinical trials is an essential step to ensure that sufficient data is generated on the safety and efficac... more

Download (193)

View PDF (201)

Treatment of Malaria (Guidelines for Clinicians)

Centers for Disease Control and Prevention CDC (2019) C_CDC

Because malaria cases are seen relatively rarely in North America, misdiagnosis by clinicians and laboratorians has been a commonly documented problem in published reports. However, malaria may be a common illness in areas where it is transmitted and therefore the diagnosis of malaria should routine... more

Download (298)

View PDF (1685)

Occupational exposures to Ebola virus in Ebola treatment center, Conakry, Guinea

Savini H, Janvier F, Karkowski L, et al. Centers for Disease Control and Prevention (2017) C_CDC

Emerg Infect Dis. 2017 Aug (Accessed July 18,2017) Abstract: We report 77 cases of occupational exposures for 57 healthcare workers at the Ebola Treatment Center in Conakry, Guinea, during the Ebola virus disease outbreak in 2014-2015. Despite the high incidence of 3.5 occupational exposures/healt... more

Download (28)

View PDF (30)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Download (101)

View PDF (129)

Guidance on Community Physical Distancing During COVID-19 Pandemic

African Union; Africa CDC Centres for Disease Control and Prevention (2020) C_CDC

This guidance document addresses how physical distancing (referred to in previous guidance documents as ‘social distancing’) can help slow down transmission.

Download (79)

View PDF (144)

Assouplir le verrouillage

African Union; Africa CDC Centres for Disease Control and Prevention (2020) CC

Considérations pour l’assouplissement des mesures sociale et de sante publique (MSSP), y compris le verrouillage dans les États membres de l’Union Afrique En réponse aux premiers cas de maladie à coronavirus 2019 (COVID-19) signalés sur le continent, de nombreux États membres de l'Union a... more

Download (200)

View PDF (240)

Enhanced COVID-19 Surveillance at the Community Level in Africa

African Union; Africa CDC Centres for Disease Control and Prevention (2021) CC

The strategy recommends that AU Member States should enhance, where feasible, existing COVID-19 surveillance to include: Community-based surveillance to detect symptomatic cases early for treatment and to avert viral transmission; Sentinel surveillance in high-risk populations to detect ... more

Download (162)

View PDF (179)

Revised COVID-19 Testing Strategy
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2022) CC

Second edition. June 2022. This revised guidance recommends that access to COVID-19 testing is decentralized as far as possible and made available at health facilities, and through the use of self tests to enable access to care and the mitigation of transmission. Testing should be prioritized for hi... more

Community use of face masks recommended

Revised COVID-19 Testing Strategy recommended

Community use of face masks
recommended

Revised COVID-19 Testing Strategy
recommended